JP2001517206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001517206A5 JP2001517206A5 JP1998509732A JP50973298A JP2001517206A5 JP 2001517206 A5 JP2001517206 A5 JP 2001517206A5 JP 1998509732 A JP1998509732 A JP 1998509732A JP 50973298 A JP50973298 A JP 50973298A JP 2001517206 A5 JP2001517206 A5 JP 2001517206A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2409896P | 1996-08-16 | 1996-08-16 | |
| US60/024,098 | 1996-08-16 | ||
| PCT/US1997/012868 WO1998006746A2 (en) | 1996-08-16 | 1997-08-04 | Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007284431A Division JP2008044969A (ja) | 1996-08-16 | 2007-10-31 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001517206A JP2001517206A (ja) | 2001-10-02 |
| JP2001517206A5 true JP2001517206A5 (enExample) | 2005-04-07 |
Family
ID=21818860
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50973298A Withdrawn JP2001517206A (ja) | 1996-08-16 | 1997-08-04 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2007284431A Withdrawn JP2008044969A (ja) | 1996-08-16 | 2007-10-31 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2011168822A Withdrawn JP2012001548A (ja) | 1996-08-16 | 2011-08-01 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2013218131A Withdrawn JP2014012738A (ja) | 1996-08-16 | 2013-10-21 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2016043177A Pending JP2016106137A (ja) | 1996-08-16 | 2016-03-07 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007284431A Withdrawn JP2008044969A (ja) | 1996-08-16 | 2007-10-31 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2011168822A Withdrawn JP2012001548A (ja) | 1996-08-16 | 2011-08-01 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2013218131A Withdrawn JP2014012738A (ja) | 1996-08-16 | 2013-10-21 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2016043177A Pending JP2016106137A (ja) | 1996-08-16 | 2016-03-07 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6187306B1 (enExample) |
| EP (1) | EP0929318B1 (enExample) |
| JP (5) | JP2001517206A (enExample) |
| AT (1) | ATE283069T1 (enExample) |
| AU (1) | AU3889997A (enExample) |
| CA (1) | CA2263503C (enExample) |
| DE (1) | DE69731756T2 (enExample) |
| WO (1) | WO1998006746A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US6277368B1 (en) | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
| US5891432A (en) * | 1997-07-29 | 1999-04-06 | The Immune Response Corporation | Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| EP1069917A4 (en) * | 1998-03-20 | 2005-02-09 | Genzyme Corp | NEW COMPLEMENTARY PAIRS OF RECEPTORS / LIGANDS AND ADOPTIVE IMMUNOTHERAPY USING THE SAME |
| GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
| US6316420B1 (en) * | 1998-07-28 | 2001-11-13 | Technion Research And Development Foundation Ltd. | DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| DE19905501B4 (de) | 1999-02-10 | 2005-05-19 | MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie | Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels |
| US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
| US6541250B2 (en) | 2000-06-22 | 2003-04-01 | Aventis Pasteur Limited | Continuous adherent melanocyte cell line |
| US20050201993A1 (en) * | 2002-10-09 | 2005-09-15 | Link Charles J.Jr. | Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| CN104911210A (zh) * | 2002-10-09 | 2015-09-16 | 衣阿华中央卫生系统 | 使用表达α(1,3)-半乳糖基转移酶的同种异型肿瘤细胞的抗肿瘤免疫 |
| GB2424273B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
| US20050136035A1 (en) * | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| CA2526120A1 (en) * | 2003-06-03 | 2005-02-24 | Cell Genesys, Inc. | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| US20050186178A1 (en) * | 2003-08-28 | 2005-08-25 | Ennist David L. | Oncolytic adenoviral vectors encoding GM-CSF |
| GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
| RU2636532C2 (ru) | 2005-05-27 | 2017-11-23 | Онкиммьюн Лимитед | Улучшенные способы иммуноанализа |
| JP6092497B2 (ja) | 2006-03-30 | 2017-03-08 | ユニバーシティー オブ カリフォルニア | 抗ｃｔｌａ−４抗体の限局性分泌のための方法および組成物 |
| US7919079B2 (en) | 2006-03-31 | 2011-04-05 | Biosante Pharmaceuticals, Inc. | Cancer immunotherapy compositions and methods of use |
| CN101632020B (zh) | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
| US7998486B2 (en) | 2006-10-25 | 2011-08-16 | Newlink Genetics Corporation | Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| AR060424A1 (es) * | 2007-04-11 | 2008-06-18 | Consejo Nac Invest Cient Tec | Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento |
| GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
| CN102666663A (zh) * | 2009-10-23 | 2012-09-12 | 道康宁东丽株式会社 | 新的有机聚硅氧烷共聚物 |
| WO2017023803A1 (en) | 2015-07-31 | 2017-02-09 | Regents Of The University Of Minnesota | Modified cells and methods of therapy |
| CA3041068A1 (en) | 2016-10-18 | 2018-04-26 | Regents Of The University Of Minnesota | Tumor infiltrating lymphocytes and methods of therapy |
| AU2017363256B2 (en) | 2016-11-22 | 2024-04-18 | Alloplex Biotherapeutics | Allogeneic tumor cell vaccine |
| JP2020530307A (ja) | 2017-06-30 | 2020-10-22 | インティマ・バイオサイエンス，インコーポレーテッド | 遺伝子治療のためのアデノ随伴ウイルスベクター |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595653A (en) | 1981-06-09 | 1986-06-17 | Lee Biomolecular Research Laboratories, Inc. | Process for assaying cellular immunity |
| US5045320A (en) | 1989-03-23 | 1991-09-03 | Medical Biology Institute | Large multivalent immunogen |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| WO1992005262A1 (en) | 1990-09-14 | 1992-04-02 | The John Hopkins University | Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| JP3580371B2 (ja) * | 1991-10-04 | 2004-10-20 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | サイトカインおよび抗原を用いた全身の免疫応答の調節 |
| US5637483A (en) * | 1991-10-04 | 1997-06-10 | Whitehead Institute For Biomedical Research | Irradiated tumor cell vaccine engineered to express GM-CSF |
| DE69533295T3 (de) * | 1994-02-16 | 2009-07-16 | The Government Of The United States Of America, As Represented By The Secretary, The Department Of Health And Human Services | Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma |
| WO1995029193A2 (en) * | 1994-04-22 | 1995-11-02 | The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services | Melanoma antigens |
| US5759535A (en) * | 1994-05-13 | 1998-06-02 | Research Corporation Technologies, Inc. | Immunotherapeutic strategies for the treatment of cancer |
-
1997
- 1997-08-04 EP EP97936164A patent/EP0929318B1/en not_active Expired - Lifetime
- 1997-08-04 DE DE69731756T patent/DE69731756T2/de not_active Expired - Lifetime
- 1997-08-04 AT AT97936164T patent/ATE283069T1/de not_active IP Right Cessation
- 1997-08-04 AU AU38899/97A patent/AU3889997A/en not_active Abandoned
- 1997-08-04 JP JP50973298A patent/JP2001517206A/ja not_active Withdrawn
- 1997-08-04 WO PCT/US1997/012868 patent/WO1998006746A2/en not_active Ceased
- 1997-08-04 CA CA2263503A patent/CA2263503C/en not_active Expired - Lifetime
- 1997-08-05 US US08/906,029 patent/US6187306B1/en not_active Expired - Lifetime
-
2007
- 2007-10-31 JP JP2007284431A patent/JP2008044969A/ja not_active Withdrawn
-
2011
- 2011-08-01 JP JP2011168822A patent/JP2012001548A/ja not_active Withdrawn
-
2013
- 2013-10-21 JP JP2013218131A patent/JP2014012738A/ja not_active Withdrawn
-
2016
- 2016-03-07 JP JP2016043177A patent/JP2016106137A/ja active Pending